Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00218101 · ClinicalTrials.gov registry record · Phase 2
Buprenorphine as a Treatment for Individuals Dependent on Analgesic Opioids
A Phase 2 study, sponsored by National Institute on Drug Abuse (NIDA).
- Completed
- Registry status
- Phase 2
- Development phase
- 10
- Enrollment target
NCT00218101 is a Phase 2 study that has completed, run by National Institute on Drug Abuse (NIDA). The registered enrollment target is 10 participants.
The verdict
NCT00218101, a Phase 2 study, has completed, sponsored by National Institute on Drug Abuse (NIDA).
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 10 participants
- Enrollment target
Study Summary
Opioids used to treat chronic pain have a high abuse potential. The purpose of this study is to determine the effectiveness of buprenorphine in treating opioid dependent individuals who abuse opioids that are prescribed for chronic pain.
Interventions
- DRUG Buprenorphine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2004-05 |
| Est. Completion | 2005-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00218101
The ClinicalTrials.gov registry entry for NCT00218101 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute on Drug Abuse (NIDA), which has 335 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Buprenorphine is the first listed.
NCT00218101 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00218101 about?
NCT00218101 is a clinical study titled "Buprenorphine as a Treatment for Individuals Dependent on Analgesic Opioids". Opioids used to treat chronic pain have a high abuse potential. The purpose of this study is to determine the effectiveness of buprenorphine in treating opioid dependent individuals who abuse opioids that are prescribed for chronic pain.
What is the current status of trial NCT00218101?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 10 participants. The study started on 2004-05. Estimated completion is 2005-03.
What interventions are being tested in trial NCT00218101?
The interventions under investigation include: Buprenorphine (DRUG).
Who is sponsoring clinical trial NCT00218101?
This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.